PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human VEGF-D (carrier-free), 10 µg
Recombinant Human VEGF-D (carrier-free), 2 µg
Recombinant Human VEGFR1 (carrier-free), 10 μg
Recombinant Human VEGFR1 (carrier-free), 25 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 10 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 100 μg
Recombinant Human VEGFR2-Fc Chimera (carrier-free), 25 μg
Recombinant Human Vitronectin (carrier-free), 100 μg
Recombinant Human Vitronectin (carrier-free), 500 μg
Recombinant Human WISP-1 (carrier-free), 20 μg
Recombinant Human WISP-1 (carrier-free), 5 μg
Recombinant Human WNT-7a (carrier-free), 15 μg
Recombinant Human WNT-7a (carrier-free), 3 μg
Recombinant Human XCL1 (carrier-free), 10 µg
Recombinant Human XCL1 (carrier-free), 100 µg
Recombinant Human XCL1 (carrier-free), 25 µg